Literature DB >> 20510832

Pain management in chronic pancreatitis: A treatment algorithm.

Shailendra Chauhan1, Chris E Forsmark.   

Abstract

Abdominal pain is common and frequently debilitating in patients with chronic pancreatitis. Medical therapy includes abstinence from tobacco and alcohol and the use of analgesics and adjunctive agents. In many patients, a trial of non-enteric-coated pancreatic enzymes and/or antioxidants may be tried. Endoscopic or surgical therapy requires careful patient selection based on a detailed analysis of pancreatic ductal anatomy. Those with a non-dilated main pancreatic duct have limited endoscopic and surgical alternatives. The presence of a dilated main pancreatic duct makes endoscopic or surgical therapy possible, which may include ductal decompression or pancreatic resection, or both. Randomised trials suggest surgical therapy is more durable and effective than endoscopic therapy. Less commonly employed options include EUS-guided coeliac plexus block, thoracoscopic splanchnicectomy, or total pancreatectomy with auto islet cell transplantation. These are used rarely when all other options have failed and only in very carefully selected patients. 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20510832     DOI: 10.1016/j.bpg.2010.03.007

Source DB:  PubMed          Journal:  Best Pract Res Clin Gastroenterol        ISSN: 1521-6918            Impact factor:   3.043


  22 in total

1.  The analgesic effect of pregabalin in patients with chronic pain is reflected by changes in pharmaco-EEG spectral indices.

Authors:  Carina Graversen; Søren S Olesen; Anne E Olesen; Kristoffer Steimle; Dario Farina; Oliver H G Wilder-Smith; Stefan A W Bouwense; Harry van Goor; Asbjørn M Drewes
Journal:  Br J Clin Pharmacol       Date:  2012-03       Impact factor: 4.335

Review 2.  A Review of Autologous Islet Transplantation.

Authors:  Michihiro Maruyama; Takashi Kenmochi; Naotake Akutsu; Kazunori Otsuki; Taihei Ito; Ikuko Matsumoto; Takehide Asano
Journal:  Cell Med       Date:  2013-05-14

3.  Additions required.

Authors:  Winfried Häuser
Journal:  Dtsch Arztebl Int       Date:  2013-10       Impact factor: 5.594

Review 4.  Chronic pancreatitis: A surgical disease? Role of the Frey procedure.

Authors:  Alexandra Roch; Jérome Teyssedou; Didier Mutter; Jacques Marescaux; Patrick Pessaux
Journal:  World J Gastrointest Surg       Date:  2014-07-27

5.  Deficient Endogenous Glucose Production During Exercise After Total Pancreatectomy/Islet Autotransplantation.

Authors:  Lindsey D Bogachus; Elizabeth Oseid; Melena Bellin; Adrian Vella; R Paul Robertson
Journal:  J Clin Endocrinol Metab       Date:  2017-09-01       Impact factor: 5.958

Review 6.  Chronic Pancreatitis: A Review.

Authors:  A K Pujahari
Journal:  Indian J Surg       Date:  2015-05-14       Impact factor: 0.656

7.  Prior surgery determines islet yield and insulin requirement in patients with chronic pancreatitis.

Authors:  Hongjun Wang; Krupa D Desai; Huansheng Dong; Stefanie Owzarski; Joseph Romagnuolo; Katherine A Morgan; David B Adams
Journal:  Transplantation       Date:  2013-04-27       Impact factor: 4.939

8.  Total pancreatectomy with islet autotransplantation: summary of a National Institute of Diabetes and Digestive and Kidney diseases workshop.

Authors:  Melena D Bellin; Andres Gelrud; Guillermo Arreaza-Rubin; Ty B Dunn; Abhinav Humar; Katherine A Morgan; Bashoo Naziruddin; Cristiana Rastellini; Michael R Rickels; Sarah J Schwarzenberg; Dana K Andersen
Journal:  Pancreas       Date:  2014-11       Impact factor: 3.327

Review 9.  The association of primary hyperparathyroidism with pancreatitis.

Authors:  Harrison X Bai; Matthew Giefer; Mohini Patel; Abrahim I Orabi; Sohail Z Husain
Journal:  J Clin Gastroenterol       Date:  2012-09       Impact factor: 3.062

10.  Deficient Glucagon Response to Hypoglycemia During a Mixed Meal in Total Pancreatectomy/Islet Autotransplantation Recipients.

Authors:  Lindsey D Bogachus; Melena D Bellin; Adrian Vella; R Paul Robertson
Journal:  J Clin Endocrinol Metab       Date:  2018-04-01       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.